Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna MRNA revealed 8 unusual trades.
Delving into the details, we found 62% of traders were bullish, while 37% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $148,500, and 5 were calls, valued at $787,414.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $90.0 and $120.0 for Moderna, spanning the last three months.
Volume & Open Interest Development
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Moderna's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale activity within a strike price range from $90.0 to $120.0 in the last 30 days.
Moderna Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| MRNA | CALL | TRADE | BULLISH | 03/15/24 | $120.00 | $665.0K | 593 | 6 |
| MRNA | PUT | TRADE | BULLISH | 01/12/24 | $107.00 | $81.8K | 99 | 430 |
| MRNA | PUT | SWEEP | BULLISH | 01/05/24 | $109.00 | $34.2K | 583 | 283 |
| MRNA | CALL | SWEEP | BEARISH | 02/16/24 | $90.00 | $33.5K | 410 | 23 |
| MRNA | PUT | TRADE | BEARISH | 02/16/24 | $105.00 | $32.5K | 356 | 63 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Moderna's Current Market Status
- With a volume of 915,430, the price of MRNA is down -0.64% at $107.88.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 49 days.
What Analysts Are Saying About Moderna
In the last month, 1 experts released ratings on this stock with an average target price of $142.0.
- An analyst from Oppenheimer has elevated its stance to Outperform, setting a new price target at $142.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
